Drugmakers are regionalising GLP-1 manufacturing as demand surges, shortages persist [...]

This Nature-published study from the 23andMe Research Institute identifies genetic [...]

Sweden-based Nanexa has reported preclinical data for a long-acting semaglutide [...]

Breast cancer remained the world’s most studied disease for the [...]

The UK’s General Pharmaceutical Council (GPhC) has formally recognised Oushk [...]

Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

Skye Bioscience has reported topline results from its Phase 2a [...]

Analysis highlights potential for benefits far beyond obesity, signalling a [...]

Imperial College London Diabetes & Endocrine Centre (ICLDEC) has expanded [...]

Purpose, precision and progress: Jenny's advice on building a career that delivers. With more than 30 years of cross-functional experience spanning manufacturing, R&D, supply chain and commercial strategy, Jenny Gattari brings a rare depth of insight to her role as Global Business Development Lead at Pfizer CentreOne.